Evidence map›Paper›PMID 31684176›Full record

ArticleMolecules (Basel, Switzerland)2019

Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation.

Moustafa Fathy, Michael Atef Fawzy, Henning Hintzsche, Toshio Nikaido, Thomas Dandekar, Eman M Othman

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Frontiers in microbiology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Moustafa FathyDepartment of Regenerative Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan. moustafa_fathyy@yahoo.com.ORCID 0000-0002-0734-5007
Michael Atef FawzyDepartment of Biochemistry, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt. michaelfawzy777@yahoo.com.
Henning HintzscheBavarian Health and Food Safety Authority, Eggenreuther Weg 43, 91058 Erlangen, Germany. hintzsche@toxi.uni-wuerzburg.de.ORCID 0000-0002-0332-2967
Toshio NikaidoDepartment of Regenerative Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan. tnikaido@med.u-toyama.ac.jp.
Thomas DandekarDepartment of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Wuerzburg, Germany. dandekar@biozentrum.uni-wuerzburg.de.ORCID 0000-0003-1886-7625
Eman M OthmanDepartment of Biochemistry, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt. eman@toxi.uni-wuerzburg.de.
University of Würzburg · DEUniversity of Toyama · JPMinia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eugenol is a phytochemical present in different plant products, e.g., clove oil. Traditionally, it is used against a number of different disorders and it was suggested to have anticancer activity. In this study, the activity of eugenol was evaluated in a human cervical cancer (HeLa) cell line and cell proliferation was examined after treatment with various concentrations of eugenol and different treatment durations. Cytotoxicity was tested using lactate dehydrogenase (LDH) enzyme leakage. In order to assess eugenol's potential to act synergistically with chemotherapy and radiotherapy, cell survival was calculated after eugenol treatment in combination with cisplatin and X-rays. To elucidate its mechanism of action, caspase-3 activity was analyzed and the expression of various genes and proteins was checked by RT-PCR and western blot analyses. Eugenol clearly decreased the proliferation rate and increased LDH release in a concentration- and time-dependent manner. It showed synergistic effects with cisplatin and X-rays. Eugenol increased caspase-3 activity and the expression of

Indexed as

Antineoplastic AgentsApoptosisCell ProliferationCell SurvivalCisplatinCombined Modality TherapyDrug Resistance, NeoplasmDrug SynergismEugenolFemaleHeLa CellsHumansUterine Cervical NeoplasmsAntineoplastic AgentsCisplatinEugenolapoptosiscisplatineugenolHeLa cellsradiation

Identifiers

PMID31684176
PMCPMC6865178
OpenAlexW2988961251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.